QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00807612. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00807612
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- NantCell, Inc.
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- AMG 479 Biological
- Carboplatin Drug
- Paclitaxel Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2010
- Last update posted
- Sep 24, 2024
2009 – 2010
United States locations
- U.S. sites
- 25
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Fayetteville | Arkansas | 72703 | — |
| Research Site | Fayetteville | Arkansas | — | — |
| Research Site | Fort Wayne | Indiana | 46845 | — |
| Research Site | Fort Wayne | Indiana | — | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Lafayette | Indiana | 47905 | — |
| Research Site | Lafayette | Indiana | — | — |
| Research Site | New Albany | Indiana | 47150 | — |
| Research Site | New Albany | Indiana | — | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | St Louis | Missouri | 63110-1093 | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Bethlehem | Pennsylvania | 18015 | — |
| Research Site | Bethlehem | Pennsylvania | — | — |
| Research Site | Greenville | South Carolina | 29605 | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Madison | Wisconsin | 53792 | — |
| Research Site | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00807612, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2024 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00807612 live on ClinicalTrials.gov.